Astrazeneca Ab

Ann-Margret Lindqvist

Ingemar Starke

Malin Anita Lemurell

Staffan Po Karlsson

Susanne Alenfalk

Fana Hunegnaw

Tore Skjaret

Mikael Dahlström

Mikael Ulf Johan Dahlstrom

Mats Peter Nordberg

Tore Skjäret

Compounds of formula (I): (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described. 

Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity

Compounds of formula (I) (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described. 

2-azetidinone derivatives and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia

Compounds of formula (I): (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described 

Diphenylazetidinone derivatives for treating disorders of the lipid metabolism

Growing community of inventors

Mölndal, Sweden

Ann-Margret Lindqvist